SLC22A1-ABCB1 Haplotype Profiles Predict Imatinib Pharmacokinetics in Asian Patients with Chronic Myeloid Leukemia
出版年份 2012 全文链接
标题
SLC22A1-ABCB1 Haplotype Profiles Predict Imatinib Pharmacokinetics in Asian Patients with Chronic Myeloid Leukemia
作者
关键词
-
出版物
PLoS One
Volume 7, Issue 12, Pages e51771
出版商
Public Library of Science (PLoS)
发表日期
2012-12-19
DOI
10.1371/journal.pone.0051771
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pretherapeutic Expression of the hOCT1 Gene Predicts a Complete Molecular Response to Imatinib Mesylate in Chronic-Phase Chronic Myeloid Leukemia
- (2012) Luciana Nardinelli et al. ACTA HAEMATOLOGICA
- Correlation between Imatinib Trough Concentration and Efficacy in Chinese Chronic Myelocytic Leukemia Patients
- (2012) Jian-Sheng Zhong et al. ACTA HAEMATOLOGICA
- Imatinib trough plasma levels do not correlate with the response to therapy in patients with chronic myeloid leukemia in routine clinical setting
- (2012) Edgar Faber et al. ANNALS OF HEMATOLOGY
- Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemia
- (2011) Sang Kyun Sohn et al. LEUKEMIA & LYMPHOMA
- Imatinib plasma trough concentration and its correlation with characteristics and response in Chinese CML patients
- (2010) Qiu-bai Li et al. ACTA PHARMACOLOGICA SINICA
- Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)
- (2010) T. P. Hughes et al. BLOOD
- Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib
- (2010) A. Haouala et al. BLOOD
- Correlation Between Imatinib Pharmacokinetics and Clinical Response in Japanese Patients With Chronic-Phase Chronic Myeloid Leukemia
- (2010) N Takahashi et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Adherence Is the Critical Factor for Achieving Molecular Responses in Patients With Chronic Myeloid Leukemia Who Achieve Complete Cytogenetic Responses on Imatinib
- (2010) David Marin et al. JOURNAL OF CLINICAL ONCOLOGY
- Genetic Polymorphisms in Organic Cation Transporter 1 (OCT1) in Chinese and Japanese Populations Exhibit Altered Function
- (2010) L. Chen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- OCT-1 activity measurement provides a superior imatinib response predictor than screening for single-nucleotide polymorphisms of OCT-1
- (2010) D L White et al. LEUKEMIA
- hOCT1 transcript levels and single nucleotide polymorphisms as predictive factors for response to imatinib in chronic myeloid leukemia
- (2010) A Bazeos et al. LEUKEMIA
- Relationship of serum imatinib trough level and response in CML patients: Long term follow-up
- (2010) Abdalla Awidi et al. LEUKEMIA RESEARCH
- Correlation between genetic polymorphisms of the hOCT1 and MDR1 genes and the response to imatinib in patients newly diagnosed with chronic-phase chronic myeloid leukemia
- (2010) Margherita Maffioli et al. LEUKEMIA RESEARCH
- Investigation of a Genome Wide Association Signal for Obesity: Synthetic Association and Haplotype Analyses at the Melanocortin 4 Receptor Gene Locus
- (2010) André Scherag et al. PLoS One
- Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Genes to Predict Response and Resistance to Imatinib Therapy in Chronic Myeloid Leukemia
- (2009) D. H. Kim et al. CLINICAL CANCER RESEARCH
- Predictors of Primary Imatinib Resistance in Chronic Myelogenous Leukemia Are Distinct From Those in Secondary Imatinib Resistance
- (2009) Wenyong W. Zhang et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacokinetic/pharmacodynamic correlation and blood-level testing in imatinib therapy for chronic myeloid leukemia
- (2009) J E Cortes et al. LEUKEMIA
- Analysis of SNPs and Haplotypes in Vitamin D Pathway Genes and Renal Cancer Risk
- (2009) Sara Karami et al. PLoS One
- Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia
- (2008) S. Dulucq et al. BLOOD
- Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study
- (2008) R. A. Larson et al. BLOOD
- Effects of imatinib (Glivec) on the pharmacokinetics of metoprolol, a CYP2D6 substrate, in Chinese patients with chronic myelogenous leukaemia
- (2008) Yanfeng Wang et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- PXR Pharmacogenetics: Association of Haplotypes with Hepatic CYP3A4 and ABCB1 Messenger RNA Expression and Doxorubicin Clearance in Asian Breast Cancer Patients
- (2008) E. Sandanaraj et al. CLINICAL CANCER RESEARCH
- Interaction of Imatinib with Human Organic Ion Carriers
- (2008) S. Hu et al. CLINICAL CANCER RESEARCH
- Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels
- (2008) Donna L. Forrest et al. LEUKEMIA RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now